CME – Page 2 – Policy & Medicine

Decrease in Commercial Support of CME Correlates with Increase in Medication Errors

Harvard Medical School Revised Conflict of Interest Policy 2010

CME Grant Disclosure and Transparency: Company Reports 2009 and 1st Qtr 2010

Boston Review: A Response to Marcia Angell’s “Big Pharma, Bad Medicine”

ACCME Adjusts Course and Provide Clarity on Industry Employees Presenting their Science

ACCME Defines Peer Review Process for Industry Scientists

PharmedOut Conference: a Prescription for Conflict or Prescription for Rhetoric?

America’s 60 Experts In Multiple Myeloma Support Continued Collaboration with Industry

Continuing Medical Education: The Need for Clarity and Resources

AMA CEJA 2010: House of Delegate Sends Back CEJA Report on CME for 4th Time